From The Guardian
A new treatment for Ebola has passed its first test by protecting monkeys from the lethal virus several days after the animals were infected.
The therapy uses an antibody that US government scientists collected from the blood of an Ebola patient more than a decade after the person recovered from the disease.
Early stage trials showed that macaques treated with the antibody developed almost complete protection against a lethal dose of Ebola up to five days after they were injected with the virus.
The antibody, known as mAb114, can now advance in human trials as a potential treatment for the disease which killed more than 10,000 people in the recent, long-running outbreak in Africa.